LifeVantage (NASDAQ:LFVN) Posts Quarterly Earnings Results, Beats Expectations By $0.08 EPS

LifeVantage (NASDAQ:LFVNGet Free Report) announced its earnings results on Wednesday. The company reported $0.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.14 by $0.08, Zacks reports. LifeVantage had a net margin of 2.11% and a return on equity of 29.24%.

LifeVantage Price Performance

LFVN opened at $20.74 on Friday. The company’s 50 day simple moving average is $19.14 and its 200-day simple moving average is $13.66. LifeVantage has a one year low of $5.22 and a one year high of $27.38. The stock has a market capitalization of $259.70 million, a P/E ratio of 64.22 and a beta of 0.84.

LifeVantage Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Monday, March 3rd will be given a dividend of $0.04 per share. The ex-dividend date is Monday, March 3rd. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.77%. LifeVantage’s payout ratio is 50.00%.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the stock. Craig Hallum started coverage on shares of LifeVantage in a research note on Tuesday, January 14th. They issued a “buy” rating and a $35.00 target price for the company. Lake Street Capital began coverage on LifeVantage in a research report on Thursday, December 19th. They issued a “buy” rating and a $26.00 price objective for the company.

View Our Latest Research Report on LifeVantage

LifeVantage Company Profile

(Get Free Report)

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.

Featured Stories

Earnings History for LifeVantage (NASDAQ:LFVN)

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.